Long-Term Efficacy and Safety of Mavacamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy: Interim Results from the MAVERICK-LTE Cohort of the MAVA-LTE Study

被引：0
|
作者：
Owens, Anjali
Sherrid, Mark V.
Wong, Timothy C.
Bach, Richard G.
Wever-Pinzon, Omar
Rigolli, Marzia
Balaratnam, Ganesh
Ma, Grace
Mealiffe, Matthew E.
Edelberg, Jay M.
机构：
来源：
CIRCULATION | 2021年 / 144卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A9685
引用
收藏
页数：3
相关论文
共 50 条
  • [1] LONG-TERM SAFETY OF MAVACAMTEN IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: INTERIM RESULTS OF THE MAVA-LONG TERM EXTENSION (LTE) STUDY
    Rader, Florian
    Choudhury, Lubna
    Saberi, Sara
    Fermin, David
    Wheeler, Matthew T.
    Abraham, Theodore P.
    Oreziak, Artur
    Garcia-Pavia, Pablo
    Zwas, Donna
    Sehnert, Amy J.
    Balaratnam, Ganesh
    Ma, Grace
    Olivotto, Iacopo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 532 - 532
  • [2] Long-Term Safety and Efficacy of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results of the PIONEER-OLE Study
    Masri, Ahmad
    Lester, Steven J.
    Stendahl, John C.
    Hegde, Sheila M.
    Sehnert, Amy J.
    Balaratnam, Ganesh
    Shah, Ashish
    Fox, Shawna
    Wang, Andrew
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (08):
  • [3] Changes in standard of care (SOC) medication during long-term mavacamten treatment for obstructive hypertrophic cardiomyopathy (HCM): results from the EXPLORER cohort of MAVA-Long-Term Extension (LTE)
    Lakdawala, N.
    Afshar, K.
    Barriales-Villa, R.
    Gimeno-Blanes, J.
    Michels, M.
    Saberi, S.
    Wheeler, M. T.
    Balaratnam, G.
    Shah, A.
    Chen, Y. M.
    Sehnert, A. J.
    Abraham, T. P.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [4] Long-Term Efficacy and Safety of Mavacamten in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy
    Day, Sharlene M.
    Udelson, James E.
    Bonow, Robert O.
    JAMA CARDIOLOGY, 2023, 8 (10) : 978 - 978
  • [5] Long-term safety and efficacy of mavacamten in obstructive hypertrophic cardiomyopathy: up to 3.5-year follow-up results of the EXPLORER cohort of MAVA-Long-Term Extension study
    Garcia-Pavia, P.
    Oreziak, A.
    Masri, A.
    Barriales-Villa, R.
    Abraham, T. P.
    Owens, A. T.
    Jensen, M.
    Wojakowski, W.
    Seidler, T.
    Hagege, A.
    Balaratnam, G.
    Shah, A.
    Fox, S.
    Hegde, S. M.
    Olivotto, I
    EUROPEAN HEART JOURNAL, 2024, 45
  • [6] Long-term effects of mavacamten treatment in obstructive hypertrophic cardiomyopathy (HCM): updated cumulative analysis of the EXPLORER cohort of MAVA-long-term extension (LTE) study up to 120 weeks
    Garcia-Pavia, P.
    Oreziak, A.
    Masri, A.
    Barriales-Villa, R.
    Abraham, T. P.
    Owens, A. T.
    Lakdawala, N. K.
    Saberi, S.
    Wang, A.
    Wheeler, M. T.
    Choudhury, L.
    Balaratnam, G.
    Fox, S.
    Hegde, S. M.
    Olivotto, I.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [7] 96-WEEK CARDIAC MAGNETIC RESONANCE (CMR) RESULTS OF TREATMENT WITH MAVACAMTEN FROM THE EXPLORER COHORT OF THE MAVA-LONG-TERM EXTENSION (LTE) STUDY IN PATIENTS (PTS) WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (HCM)
    Saberi, Sara
    Kramer, Christopher M.
    Oreziak, Artur
    Masri, Ahmad
    Villa, Roberto Barriales
    Abraham, Theodore P.
    Lakdawala, Neal K.
    Wang, Andrew
    Choudhury, Lubna
    Rader, Florian
    Hegde, Sheila M.
    Kwong, Raymond Y.
    Balaratnam, Ganesh
    Kurio, Greg
    Fox, Shawna
    Olivotto, Iacopo
    Owens, Anjali Tiku
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 326 - 326
  • [8] Efficacy of Mavacamten in Patients with Symptomatic Hypertrophic Cardiomyopathy: Sub-Group Analyses by Background Beta-Blocker Use from the EXPLORER- HCM and MAVA-LTE Studies
    Jacoby, Daniel L.
    Wheeler, Matthew T.
    Elliott, Perry M.
    Saberi, Sara
    Sehnert, Amy J.
    Edelberg, Jay M.
    Li, Wanying
    Olivotto, Iacopo
    CIRCULATION, 2021, 144
  • [9] LONG-TERM RESULTS OF THERAPY FOR HYPERTROPHIC NON-OBSTRUCTIVE CARDIOMYOPATHY WITH VERAPAMIL
    KUHN, H
    THELEN, U
    LEUNER, C
    KOHLER, E
    BLUSCHKE, V
    ZEITSCHRIFT FUR KARDIOLOGIE, 1980, 69 (03): : 187 - 187
  • [10] LONG-TERM SAFETY AND EFFICACY OF MAVACAMTEN IN PATIENTS (PTS) WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (HCM): UPDATED RESULTS FROM THE PIONEER-OLE STUDY
    Masri, Ahmad
    Lester, Steven J.
    Stendahl, John
    Hegde, Sheila M.
    Sehnert, Amy
    Balaratnam, Ganesh
    Fox, Shawna
    Wang, Andrew
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 346 - 346
12345